Albert Bourla's comments continue a roller-coaster pattern of differing communication from the pharmaceutical company and the government as the pandemic enters its third year.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
